Hakluyt Capital announces three of its first investments

We are delighted to announce three of our first investments – in Interos, CalypsoAI and Viz.ai.

Interos’ AI-powered platform is helping the world’s leading multinational corporations, governments, and other organisations map, monitor and pre-empt emerging and systemic risks hidden deep in manufacturing and cyber supply chains to protect brand, reputation and profitability.

CalypsoAI is a leading AI Security company empowering international organisations to leverage generative AI and Large Language Models (LLMs) safely and confidently. The company’s platform is designed to mitigate the risks posed by generative AI models, providing industry-leading safeguards that prevent the leakage of sensitive data and block malicious attacks.

Viz.ai’s software platform harnesses AI to accelerate the diagnosis and treatment of serious illnesses. Its algorithms, which have been cleared by the US Food and Drug Administration (FDA), analyse medical imaging data such as CT scans and electrocardiograms to support medical professionals with real-time insights and assessments.

“Our ambition in building Hakluyt Capital is to partner with the world’s most dynamic and ambitious young companies, and accelerate their growth. We are delighted to be using Hakluyt’s in-house expertise and connectivity to advise these brilliant businesses on how best to navigate their toughest challenges and seize their greatest opportunities.”

Varun Chandra, chairman of Hakluyt Capital and managing partner of Hakluyt

On Hakluyt Capital’s investment in Interos, founder and CEO Jennifer Bisceglie commented: “Hakluyt Capital offers a tremendous opportunity for high-growth businesses like Interos, and they are aligned to our vision for proactive resilience. We have already felt the benefits of the firm’s outstanding network and insights, and are thrilled to continue innovating alongside them as we scale further.”

Neil Serebryany, founder and CEO of CalypsoAI, said: “To scale a start-up in today’s environment, you need more than just investment. Hakluyt’s unique expertise will be crucial for the next stages in CalypsoAI’s journey.”

Dr Chris Mansi, co-founder and CEO of Viz.ai, added: “We operate in a very complex regulatory environment, and Hakluyt’s advice has already been extremely valuable to us. We greatly look forward to continuing our partnership with them.”